Translational Genito-Urinary Cancer Research
Selected Publications
Cathomas, Richard, Petrausch, Ulf, Hayoz, Stefanie, Spahn, Martin, Bubendorf, Lukas, Schäuble, Karin, Strebel, Räto T., Niederberger, Philipp, Stenner, Frank, Hirschi, Anita, Vogl, Ursula, Lorch, Anja, Tsantoulis, Petros, Aeppli, Stefanie, Erdmann, Andreas, Fischer Maranta, Angela, Fankhauser, Christian, Hötker, Andreas M., Pausch, Antonia M., et al. (2026). Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19. Journal of Clinical Oncology, 44, 1911–1920. https://doi.org/10.1200/JCO-26-00845
Cathomas, Richard, Petrausch, Ulf, Hayoz, Stefanie, Spahn, Martin, Bubendorf, Lukas, Schäuble, Karin, Strebel, Räto T., Niederberger, Philipp, Stenner, Frank, Hirschi, Anita, Vogl, Ursula, Lorch, Anja, Tsantoulis, Petros, Aeppli, Stefanie, Erdmann, Andreas, Fischer Maranta, Angela, Fankhauser, Christian, Hötker, Andreas M., Pausch, Antonia M., et al. (2026). Addition of Intravesical Recombinant Bacillus Calmette-Guérin to Perioperative Chemoimmunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/19. Journal of Clinical Oncology, 44, 1911–1920. https://doi.org/10.1200/JCO-26-00845
Wetterauer, Christian, Matthias, Mark, Pueschel, Heike, Deckart, Alexander, Bubendorf, Lukas, Mortezavi, Ashkan, Arbelaez, Emilio, Jean Winkel, David, Heye, Tobias, Boll, Daniel T., Merkle, Elmar, Hayoz, Stefanie, Seifert, Helge H., & (2024). Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING). European Urology Focus, 10(2), 332–338. https://doi.org/10.1016/j.euf.2024.02.006
Wetterauer, Christian, Matthias, Mark, Pueschel, Heike, Deckart, Alexander, Bubendorf, Lukas, Mortezavi, Ashkan, Arbelaez, Emilio, Jean Winkel, David, Heye, Tobias, Boll, Daniel T., Merkle, Elmar, Hayoz, Stefanie, Seifert, Helge H., & (2024). Opportunistic Prostate Cancer Screening with Biparametric Magnetic Resonance Imaging (VISIONING). European Urology Focus, 10(2), 332–338. https://doi.org/10.1016/j.euf.2024.02.006
Garioni, Michele, Tschan, Viviane J., Blukacz, Lauriane, Nuciforo, Sandro, Parmentier, Romuald, Roma, Luca, Coto-Llerena, Mairene, Pueschel, Heike, Piscuoglio, Salvatore, Vlajnic, Tatjana, Stenner, Frank, Seifert, Hans-Helge, , Bubendorf, Lukas, & Le Magnen, Clémentine. (2023). Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. Npj Precision Oncology, 7(1). https://doi.org/10.1038/s41698-023-00466-w
Garioni, Michele, Tschan, Viviane J., Blukacz, Lauriane, Nuciforo, Sandro, Parmentier, Romuald, Roma, Luca, Coto-Llerena, Mairene, Pueschel, Heike, Piscuoglio, Salvatore, Vlajnic, Tatjana, Stenner, Frank, Seifert, Hans-Helge, , Bubendorf, Lukas, & Le Magnen, Clémentine. (2023). Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. Npj Precision Oncology, 7(1). https://doi.org/10.1038/s41698-023-00466-w
, Thalmann GN, Lucca I, Kwiatkowski M, Wirth GJ, Strebel RT, Engeler D, Pedrazzini A, Hüttenbrink C, Schultze-Seemann W, Torpai R, Bubendorf L, Wicki A, Roth B, Bosshard P, Püschel H, Boll DT, Hefermehl L, Roghmann F, et al. (2022). A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. European Urology Oncology, 5(2), 195–202. https://doi.org/10.1016/j.euo.2021.12.006
, Thalmann GN, Lucca I, Kwiatkowski M, Wirth GJ, Strebel RT, Engeler D, Pedrazzini A, Hüttenbrink C, Schultze-Seemann W, Torpai R, Bubendorf L, Wicki A, Roth B, Bosshard P, Püschel H, Boll DT, Hefermehl L, Roghmann F, et al. (2022). A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. European Urology Oncology, 5(2), 195–202. https://doi.org/10.1016/j.euo.2021.12.006
